Home › Liver Cancer › Missouri › Kansas City
Liver Cancer clinical trials in Kansas City, MO
3 studies for Liver Cancer are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
RecruitingPhase 1/2
- Saint Luke's Cancer Institute, Kansas City
- Saint Luke's Hospital of Kansas City, Kansas City
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Saint Luke's Cancer Institute, East, Kansas City
- Saint Luke's Cancer Institute, Kansas City
- Saint Luke's Cancer Institute, Kansas City North, Kansas City
- and 1 more
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Kansas City
About Liver Cancer
The most common form of liver cancer in adults is hepatocellular carcinoma. Learn about diagnosis, treatment and taking part in research studies.
More about Liver Cancer on MedlinePlus
Liver Cancer trials in other cities
- Houston, TX14 studies
- Cleveland, OH11 studies
- Los Angeles, CA11 studies
- Dallas, TX10 studies
- Boston, MA9 studies
- Chicago, IL8 studies
- St. Louis, MO8 studies
- Philadelphia, PA7 studies
- Durham, NC7 studies
- San Francisco, CA6 studies
- New York City, NY6 studies
- Washington, DC6 studies
Other studies in Kansas City
- Breast Cancer34 studies
- Non-Small Cell Lung Cancer31 studies
- Heart Failure25 studies
- Cancer (all types)21 studies
- Lung Cancer19 studies
- Colorectal Cancer16 studies
- Metastatic Cancer15 studies
- Acute Myeloid Leukemia15 studies
- Prostate Cancer14 studies
- Ovarian Cancer11 studies
- Obesity11 studies
- Type 2 Diabetes11 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.